Myriad Genetics DTC Ads For BRACAnalysis To Focus On Prevention Market
This article was originally published in The Gray Sheet
Executive Summary
Myriad Genetics will concentrate direct-to-consumer advertising in Atlanta and Denver for its BRACAnalysis breast and ovarian cancer genetic predisposition testing service as the firm moves beyond physician education as a sole means of promotion
You may also be interested in...
Genetic Test DTC Advertising Criteria Will Hinge On Clinical Utility
Assessing the clinical utility of specific genetic tests will be paramount as stakeholders collaborate on a "best practices" document for genetic test direct-to-consumer marketing and advertising
Genetic Test DTC Advertising Criteria Will Hinge On Clinical Utility
Assessing the clinical utility of specific genetic tests will be paramount as stakeholders collaborate on a "best practices" document for genetic test direct-to-consumer marketing and advertising
CDC Readies Survey To Assess Impact Of DTC Genetic Test Ads On Public
CDC's Office of Genomics & Disease Prevention will begin in the next few weeks a survey to assess knowledge and attitudes about genetic testing among physicians and the general public